Abramson Cancer Center multiple myeloma clinicians and researchers have led the way nationally for years in the diagnosis and treatment of multiple myeloma.
Today, there more hope than ever for those diagnosed with multiple myeloma. Our team has worked together for years. By putting our experience to work we offer the best possible treatment outcomes.
If diagnosed with Multiple Myeloma, it's important to have the best team of experts available.
At Penn's Multiple Myeloma Program there are individuals nationally recognized for their expertise. They can provide the information, care and support to help each step of the way.
Penn has one of the few Hematologic Malignancy (leukemia, lymphoma and myeloma) Research Programs in the country that is approved and funded by the National Cancer Institute.
The knowledge gained through our research allows us to better care for those with multiple myeloma.
To learn about what sets us apart, visit:
Nicholas Martell was first diagnosed with prostate cancer more than ten years ago. He was healthy for many years after being treated with radiation therapy. Nick recently experienced a recurrence of his cancer. Physicians at Penn tailored his treatment and enrolled him in a new Phase I clinical trial using laser-based photodynamic therapy (PDT) followed by hormone therapy. This leading edge treatment plan was effective. Nick just returned from a vacation with his daughter, and in his free time, he plays golf every chance he gets.
Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.